Morgan Stanley’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.85M Buy
2,972,269
+1,077,135
+57% +$2.84M ﹤0.01% 3675
2025
Q1
$5.7M Sell
1,895,134
-2,110,680
-53% -$6.35M ﹤0.01% 3815
2024
Q4
$10.3M Buy
4,005,814
+1,758,922
+78% +$4.5M ﹤0.01% 3389
2024
Q3
$8.36M Buy
2,246,892
+1,678,491
+295% +$6.24M ﹤0.01% 3561
2024
Q2
$3.59M Sell
568,401
-56,200
-9% -$355K ﹤0.01% 4152
2024
Q1
$3.35M Sell
624,601
-574,835
-48% -$3.09M ﹤0.01% 4225
2023
Q4
$6.02M Buy
1,199,436
+801,535
+201% +$4.02M ﹤0.01% 4265
2023
Q3
$672K Buy
397,901
+47,254
+13% +$79.9K ﹤0.01% 5013
2023
Q2
$975K Sell
350,647
-223,119
-39% -$620K ﹤0.01% 4847
2023
Q1
$1.04M Buy
573,766
+29,608
+5% +$53.9K ﹤0.01% 4832
2022
Q4
$2.76M Sell
544,158
-97,655
-15% -$495K ﹤0.01% 4241
2022
Q3
$3.19M Sell
641,813
-336,830
-34% -$1.67M ﹤0.01% 4055
2022
Q2
$3.64M Sell
978,643
-94,876
-9% -$353K ﹤0.01% 4032
2022
Q1
$6.02M Buy
1,073,519
+640,695
+148% +$3.59M ﹤0.01% 3479
2021
Q4
$2.63M Sell
432,824
-64,900
-13% -$395K ﹤0.01% 4352
2021
Q3
$4.85M Buy
497,724
+9,434
+2% +$91.9K ﹤0.01% 3743
2021
Q2
$6.97M Buy
488,290
+155,215
+47% +$2.22M ﹤0.01% 3419
2021
Q1
$7.91M Buy
333,075
+13,186
+4% +$313K ﹤0.01% 2901
2020
Q4
$4.27M Buy
319,889
+63,462
+25% +$846K ﹤0.01% 3426
2020
Q3
$1.78M Sell
256,427
-26,053
-9% -$181K ﹤0.01% 3762
2020
Q2
$3.47M Buy
282,480
+216,945
+331% +$2.66M ﹤0.01% 3050
2020
Q1
$189K Buy
65,535
+55,428
+548% +$160K ﹤0.01% 4889
2019
Q4
$38K Buy
10,107
+173
+2% +$650 ﹤0.01% 5935
2019
Q3
$12K Sell
9,934
-38,563
-80% -$46.6K ﹤0.01% 6147
2019
Q2
$50K Buy
48,497
+36,486
+304% +$37.6K ﹤0.01% 5603
2019
Q1
$19K Sell
12,011
-53,198
-82% -$84.2K ﹤0.01% 6021
2018
Q4
$76K Sell
65,209
-39,193
-38% -$45.7K ﹤0.01% 5642
2018
Q3
$385K Sell
104,402
-115,999
-53% -$428K ﹤0.01% 5136
2018
Q2
$674K Buy
220,401
+23,206
+12% +$71K ﹤0.01% 4894
2018
Q1
$767K Buy
197,195
+88,590
+82% +$345K ﹤0.01% 4734
2017
Q4
$488K Buy
108,605
+46,425
+75% +$209K ﹤0.01% 4992
2017
Q3
$341K Buy
62,180
+24,886
+67% +$136K ﹤0.01% 5094
2017
Q2
$282K Buy
37,294
+1,664
+5% +$12.6K ﹤0.01% 5145
2017
Q1
$127K Sell
35,630
-32,814
-48% -$117K ﹤0.01% 5510
2016
Q4
$392K Buy
68,444
+48,958
+251% +$280K ﹤0.01% 5061
2016
Q3
$151K Sell
19,486
-6,681
-26% -$51.8K ﹤0.01% 5130
2016
Q2
$163K Buy
26,167
+10,619
+68% +$66.1K ﹤0.01% 5032
2016
Q1
$128K Buy
15,548
+8,842
+132% +$72.8K ﹤0.01% 5197
2015
Q4
$117K Sell
6,706
-132,279
-95% -$2.31M ﹤0.01% 5323
2015
Q3
$1.59M Buy
+138,985
New +$1.59M ﹤0.01% 3716